top of page
Home
Scientific Publications
Contact
More
Use tab to navigate through the menu items.
Scientific Publications
All News
E-Antigens
SUV39H1 Inactivation
Cell Therapy Assets
Search
CELL - Transposable element exonization generates a reservoir of evolving and functional protein isoforms
Dec 26, 2024
POSTER - A novel dark genome-derived pMHC target for glioblastoma immunotherapy
Nov 21, 2024
IMMUNOWATCH #10 - Developing a robust, tumour-specific target discovery platform for next-generation immunotherapies
Aug 1, 2024
CANCER DISCOVERY - Disruption of SUV39H1-mediated methylation sustains CAR T cell function
Nov 7, 2023
CANCER DISCOVERY - Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors
Nov 7, 2023
SCIENCE IMMUNOLOGY - Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer
Feb 3, 2023
SCIENCE IMMUNOLOGY - Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements
Feb 3, 2023
NATURE COMMUNICATIONS - CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by SUV39H1 in melanomas
Jun 29, 2022
CELL REPORTS - Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements enconding HLA-I-presented peptides
Jun 7, 2022
NATURE MEDICINE - HLA-independent T cell receptors for targeting tumors with low antigen density
Jan 13, 2022
NATURE MEDICINE - Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Dec 17, 2018
Up
bottom of page
